Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 7Head & Neck 3Breast 3Thoracic 2Sarcoma 2Gynecologic 2Gastrointestinal 2Myeloid 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Brain Neoplasms 104Glioblastoma 99Glioma 80Neuroblastoma 32Central Nervous System Neoplasms 28Neoplasms 24Medulloblastoma 24Astrocytoma 24Sarcoma 22Meningioma 22Ependymoma 22Neurofibromatosis 1 20Melanoma 17Rhabdoid Tumor 16Breast Neoplasms 16Wilms Tumor 14Neurofibroma, Plexiform 14Rhabdomyosarcoma 13Osteosarcoma 13Hepatoblastoma 13Thyroid Neoplasms 12Sarcoma, Ewing 12Gliosarcoma 12Carcinoma, Non-Small-Cell Lung 12Diffuse Intrinsic Pontine Glioma 11Recurrence 10Pheochromocytoma 10Pancreatic Neoplasms 10Ovarian Neoplasms 10Lymphoma, Non-Hodgkin 10

Interventions

temsirolimus 1Valproic Acid 1Sirolimus 1Immunoglobulin G 1Disulfides 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × CNS × 30 days × Clear all
NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡